reviewNew England Journal of MedicineNov 10, 2010Closed access

Triple-Negative Breast Cancer

McGill University Health Centre · Jewish General Hospital · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.

Citation impact

4,153
total citations
FWCI
44.37
Percentile
100%
References
71
Citations per year

Authors

3

Topics & keywords

Keywords
  • Medicine
  • Breast cancer
  • Progesterone receptor
  • Estrogen receptor
  • Triple-negative breast cancer
  • Cancer
  • Oncology
  • Triple negative
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.